You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Managing Postmenopausal Osteoporosis: AACE Guideline Updates and What They Mean for Your Patients

  • Authors: Steven Petak, MD, JD; Rachel Pessah-Pollack, MD, FACE; Jennifer Kelly, DO
  • CME Released: 6/5/2020
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 6/5/2021
Start Activity


Target Audience and Goal Statement

This activity is intended for endocrinologists, orthopedists & orthopedic surgeons, and primary care physicians.

The goal of this activity is to inform clinicians of the most recent guideline updates for the management of osteoporosis among postmenopausal women, as well as discuss how to apply guideline recommendations in clinical practice to reduce the risk of fracture among postmenopausal women with osteoporosis.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Latest guideline updates on the management of osteoporosis among postmenopausal women
  • Have greater competence related to
    • Applying guideline recommendations and the latest treatment advances into clinical practice to reduce the risk of fracture among individuals with osteoporosis


Disclosures

Learner Bill of Rights
The American Association of Clinical Endocrinologists (AACE) recognizes that you are a lifelong learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge, skill, or performance. As part of AACE's duty to you as a learner, you have the right to expect that your continuing medical education experience with AACE includes:

CONTENT that:

Promotes improvements or quality in healthcare;
Is valid, reliable, and accurate;
Offers balanced presentations that are free of commercial bias for or against a product/service;
Is vetted through a process that resolves any conflicts of interests of planners, teachers, or authors;
Is driven and based on learning needs, not commercial interests;
Addresses the stated objectives or purpose; and
Is evaluated for its effectiveness in meeting the identified educational need.

A LEARNING ENVIRONMENT that:

Supports learners' ability to meet their individual needs;
Respects and attends to any special needs of the learners;
Respects the diversity of groups of learners; and
Is free of promotional, commercial, and/or sales activities.

DISCLOSURE of:

Relevant financial relationships planners, teachers, and authors have with commercial interests related to the content of the activity; and
Commercial support (funding or in-kind resources) of the activity.

Declaration of Disclosure and Conflicts of Interest

It is the policy of AACE to ensure balance, independence, objectivity and scientific rigor in all of its CME activities. Presentation content may include discussion of an unlabeled or an investigational use of a product. AACE requires that participating faculty disclose to the audience any product(s) and its use(s) discussed in the educational activity that are unapproved/unlabeled for the use by the FDA or still considered investigational in nature.

Everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships. "Relevant financial relationships" are financial relationships in any amount occurring within the past 12 months that create a conflict of interest. AACE requires speakers, faculty, CME Committee and other individuals who are in a position to control the content of this educational activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly evaluated by AACE for fair balance, scientific objectivity of studies mentioned in the presentation and educational materials used as basis for content, and appropriateness of patient care recommendations.

The intent of this disclosure is not to prevent a speaker with commercial affiliations from presenting, but rather to provide learners with information from which they may make their own judgments. Informed learners are the final safeguards in assuring that a CME activity is independent from commercial influence.

AACE has reviewed all disclosures and resolved or managed all identified conflicts of interest for this educational activity, as applicable.


Faculty

  • Steven Petak, MD, JD

    Associate Clinical Professor
    Weill Cornell College
    Division Head and Chief
    Endocrinology
    Houston Methodist Hospital
    Texas Medical Center
    Houston, Texas

    Disclosures

    Disclosure: Steven Petak, MD, JD has disclosed the following relevant financial relationships:
    Served as a speaker or a member of a speakers bureau for: Alexion; Amgen; Radius Health, Inc.

  • Rachel Pessah-Pollack, MD, FACE

    Clinical Associate Professor
    Division of Endocrinology, Diabetes, and Metabolism
    NYU Langone Health
    New York, New York

    Disclosures

    Disclosure: Rachel Pessah-Pollack, MD, FACE, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Boehringer Ingelheim; Eli Lilly; Radius Health, Inc.; Sanofi
    Served as a speaker or a member of a speakers bureau for: Boehringer Ingelheim; Eli Lilly; Radius Health, Inc.; Sanofi

  • Jennifer Kelly, DO

    Director
    Metabolic Bone Program
    Vermont Medical Center
    Associate Professor
    Department of Medicine
    Division of Endocrinology and Diabetes Larner College of Medicine
    University of Vermont
    Burlington, Vermont

    Disclosures

    Disclosure: Jennifer Kelly, DO, has disclosed the following relevant financial relationships:
    Received grants for clinical research from: Takeda

Editors

  • Karen Badal, MD, MPH

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Karen Badal, MD, MPH, has disclosed the following relevant financial relationships:
    Owns stock, stock options or bonds, from: Kallyope, Inc.

  • Heather Lewin, MAT

    Associate Director, Medscape, LLC

    Disclosures

    Disclosure: Heather Lewin, MAT, has disclosed no relevant financial relationships.

Content Reviewer

  • Robert Morris, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: ViiV Healthcare
    Owns stock, stock options, or bonds from: GlaxoSmithKline

Medscape, LLC staff have disclosed that they have no relevant financial relationships.


Accreditation Statements

Developed through a partnership between Medscape and the American Association of Clinical Endocrinologists (AACE).

    For Physicians

  • The American Association of Clinical Endocrinologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The American Association of Clinical Endocrinologists (AACE) designates this enduring material for a maximum of  1.0 AMA PRA Category 1 Credit(s)™.Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    For questions regarding this CME activity, please contact:
    AACE CME Department
    Phone: (904) 353-7878
    Contact this provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Managing Postmenopausal Osteoporosis: AACE Guideline Updates and What They Mean for Your Patients

Authors: Steven Petak, MD, JD; Rachel Pessah-Pollack, MD, FACE; Jennifer Kelly, DOFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME Released: 6/5/2020

Valid for credit through: 6/5/2021

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Managing Postmenopausal Osteoporosis: The AACE Guideline Updates and What They Mean for Your Patients

Introduction to Postmenopausal Osteoporosis
Steven Petak, MD, JD

Updated Recommendations on the Diagnosis and Management of Postmenopausal Osteoporosis

Examining the AACE Guidelines
Steven Petak, MD, JD, and Rachel Pessah-Pollack, MD, FACE

Therapeutics of Postmenopausal Osteoporosis

Navigating the Nuance of Risk Fracture
Steven Petak, MD, JD, and Jennifer Kelly, DO
 
  • Print